Vertex’s effort to provide fertility support services to those on government insurance programs who want to take the ...
HHS had argued that Vertex's plan to cover fertility services for some patients that took its gene therapy would violate anti-kickback and inducement laws.
The Trump administration’s cuts to a global AIDS relief program threaten to upend rollout of a groundbreaking HIV prevention ...
Trump's upcoming tariffs has the potential to bring biopharma manufacturing to the US, which could impact companies with ...
Homes and Gardens on MSN7h
It's your last chance to buy one of our all-time favorite Shark upright vacuums in the Walmart sale – I'm a vacuum tester, and it's a seriously worthy upgradeShark is our go-to brand for upright vacuums, with their range of powerful and truly useful vacuums dominating the upright ...
Pharmaceutical Technology on MSN1d
Vertex halts development of diabetes cell therapy after trial failureVertex continues to develop type 1 diabetes therapy, zimislecel, which is being investigated in a Phase III trial.
Vertex is ending work on one of its two clinical-stage islet cell treatments after the diabetes therapy looked unlikely to ...
The ASX took a hit on tariff fears with markets dropping globally. Gold soared to new highs and eyes turn to the RBA’s rate decision.
ASX tanks on "Liberation Day" worries with gold hitting records, while iron ore, tech stocks, and Qantas take a hit.
Vertex Software faces strong competition and slower growth, leading to a neutral rating. See why VERX stock remains pricey ...
Vertex Pharmaceuticals will not advance clinical trials of a treatment for Type 1 diabetes after efficacy data failed to support further clinical advancement.
With President Donald Trump expected to levy tariffs on pharmaceuticals manufactured outside the United States, industry ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback